EROC compared with PLSE: revenue, margins and what each company keeps, and the suppliers and customers both name

EROCERock, Inc.

Mkt capRevenueRevenue

PLSEPulse Biosciences, Inc.

Mkt capRevenueRevenue

Compare

EROCERock, Inc.

PLSEPulse Biosciences, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

EROC: latest quarter is a loss; flow not drawable. PLSE: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

No disclosed counterparties: EROC, PLSE.

Role chip = supplier or customerSource: SEC EDGAR

EROCERock, Inc.

8.99▲+13.78%· post 8.98

Mkt cap$431.6MRevenue$40MQ2 FY26

PLSEPulse Biosciences, Inc.

52.82▼−0.16%· post 51.86

ClosedNov 3 '26

Mkt cap$3.7BRevenue$434,000Q2 FY26

Compare

ClosedNov 3 '26

EROCERock, Inc.

PLSEPulse Biosciences, Inc.

8.99▲+13.78%post 8.98

Price

52.82▼−0.16%post 51.86

$431.6M

Mkt cap

$3.7B

Q2 FY26$40M

Revenue

$434,000Q2 FY26

EROC8.99▲+13.78%vsPLSE52.82▼−0.16%ClosedNov 3 '26

Price

rebased to 0%

EROC, solidPLSE, dashed